| positive regulation of transcription dna templated | GO:0045893 | 266 | 0.446 | |
| positive regulation of nitrogen compound metabolic process | GO:0051173 | 354 | 0.436 | |
| rna splicing | GO:0008380 | 83 | 0.423 | Human |
| chromosome organization | GO:0051276 | 360 | 0.392 | Human |
| positive regulation of nucleic acid templated transcription | GO:1903508 | 266 | 0.340 | |
| mitotic cell cycle phase transition | GO:0044772 | 138 | 0.318 | |
| ribonucleoside catabolic process | GO:0042454 | 112 | 0.315 | |
| regulation of cell cycle phase transition | GO:1901987 | 130 | 0.301 | |
| positive regulation of nucleobase containing compound metabolic process | GO:0045935 | 332 | 0.300 | |
| cell proliferation | GO:0008283 | 299 | 0.293 | |
| regulation of transcription from rna polymerase ii promoter | GO:0006357 | 378 | 0.290 | |
| regulation of cell cycle process | GO:0010564 | 181 | 0.288 | |
| regulation of mitotic cell cycle | GO:0007346 | 190 | 0.266 | |
| regulation of cell proliferation | GO:0042127 | 163 | 0.244 | |
| positive regulation of biosynthetic process | GO:0009891 | 316 | 0.233 | |
| nucleosome mobilization | GO:0042766 | 9 | 0.221 | |
| positive regulation of transcription from rna polymerase ii promoter | GO:0045944 | 204 | 0.220 | |
| positive regulation of macromolecule biosynthetic process | GO:0010557 | 283 | 0.207 | |
| chromatin organization | GO:0006325 | 207 | 0.205 | |
| negative regulation of gene expression | GO:0010629 | 387 | 0.198 | Human |
| regulation of organ growth | GO:0046620 | 42 | 0.197 | |
| intracellular receptor signaling pathway | GO:0030522 | 19 | 0.185 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 27 | 0.167 | |
| negative regulation of biosynthetic process | GO:0009890 | 277 | 0.166 | |
| mitotic dna integrity checkpoint | GO:0044774 | 75 | 0.161 | |
| cellular protein modification process | GO:0006464 | 438 | 0.147 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 174 | 0.145 | |
| spindle organization | GO:0007051 | 253 | 0.143 | |
| chromatin modification | GO:0016568 | 147 | 0.127 | |
| small molecule metabolic process | GO:0044281 | 305 | 0.126 | |
| negative regulation of macromolecule biosynthetic process | GO:0010558 | 270 | 0.125 | |
| regulation of mrna processing | GO:0050684 | 71 | 0.119 | Human |
| regulation of localization | GO:0032879 | 275 | 0.115 | |
| positive regulation of gene expression | GO:0010628 | 290 | 0.115 | |
| glycosyl compound catabolic process | GO:1901658 | 112 | 0.113 | |
| mitotic spindle organization | GO:0007052 | 220 | 0.112 | |
| dna metabolic process | GO:0006259 | 227 | 0.109 | Human |
| transcription from rna polymerase ii promoter | GO:0006366 | 368 | 0.108 | |
| purine nucleoside catabolic process | GO:0006152 | 112 | 0.103 | |
| response to monosaccharide | GO:0034284 | 4 | 0.102 | |
| mrna metabolic process | GO:0016071 | 124 | 0.100 | Human |
| positive regulation of rna biosynthetic process | GO:1902680 | 266 | 0.098 | |
| gene silencing by rna | GO:0031047 | 57 | 0.097 | |
| intracellular signal transduction | GO:0035556 | 300 | 0.095 | |
| cell cycle checkpoint | GO:0000075 | 95 | 0.094 | |
| mitotic cell cycle checkpoint | GO:0007093 | 88 | 0.091 | |
| positive regulation of organelle organization | GO:0010638 | 65 | 0.085 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 45 | 0.083 | |
| organonitrogen compound catabolic process | GO:1901565 | 128 | 0.083 | |
| small gtpase mediated signal transduction | GO:0007264 | 88 | 0.082 | |
| sensory organ morphogenesis | GO:0090596 | 260 | 0.078 | |
| regulation of cell cycle | GO:0051726 | 291 | 0.078 | |
| positive regulation of rna metabolic process | GO:0051254 | 271 | 0.077 | |
| negative regulation of transcription dna templated | GO:0045892 | 237 | 0.077 | |
| heterochromatin organization | GO:0070828 | 25 | 0.075 | |
| protein modification process | GO:0036211 | 438 | 0.073 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 130 | 0.073 | |
| positive regulation of phosphate metabolic process | GO:0045937 | 139 | 0.072 | |
| positive regulation of endopeptidase activity | GO:0010950 | 26 | 0.070 | |
| vesicle mediated transport | GO:0016192 | 381 | 0.069 | |
| peptidyl lysine methylation | GO:0018022 | 16 | 0.068 | |
| positive regulation of macromolecule metabolic process | GO:0010604 | 405 | 0.066 | |
| regulation of alternative mrna splicing via spliceosome | GO:0000381 | 60 | 0.062 | |
| response to glucose | GO:0009749 | 2 | 0.062 | |
| ribose phosphate metabolic process | GO:0019693 | 145 | 0.062 | |
| regulation of cell differentiation | GO:0045595 | 302 | 0.062 | Human |
| nucleoside catabolic process | GO:0009164 | 112 | 0.061 | |
| lateral inhibition | GO:0046331 | 206 | 0.061 | |
| negative regulation of cell proliferation | GO:0008285 | 69 | 0.059 | |
| oocyte construction | GO:0007308 | 112 | 0.058 | |
| regulation of intracellular signal transduction | GO:1902531 | 236 | 0.057 | |
| establishment of localization in cell | GO:0051649 | 402 | 0.057 | |
| dna packaging | GO:0006323 | 91 | 0.057 | Human |
| organelle fission | GO:0048285 | 340 | 0.055 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 108 | 0.055 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 145 | 0.055 | |
| dna damage checkpoint | GO:0000077 | 78 | 0.054 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 108 | 0.054 | |
| nucleoside phosphate catabolic process | GO:1901292 | 110 | 0.053 | |
| rna splicing via transesterification reactions | GO:0000375 | 73 | 0.052 | Human |
| response to abiotic stimulus | GO:0009628 | 341 | 0.052 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 109 | 0.051 | |
| chromosome segregation | GO:0007059 | 157 | 0.050 | |
| negative regulation of cell cycle process | GO:0010948 | 109 | 0.050 | |
| nucleotide catabolic process | GO:0009166 | 109 | 0.049 | |
| histone methylation | GO:0016571 | 40 | 0.048 | |
| carbohydrate derivative metabolic process | GO:1901135 | 217 | 0.048 | |
| positive regulation of cellular component organization | GO:0051130 | 156 | 0.047 | |
| organophosphate metabolic process | GO:0019637 | 195 | 0.047 | |
| chromatin assembly | GO:0031497 | 48 | 0.046 | |
| heterocycle catabolic process | GO:0046700 | 166 | 0.045 | |
| purine containing compound catabolic process | GO:0072523 | 112 | 0.043 | |
| mrna processing | GO:0006397 | 104 | 0.043 | Human |
| response to temperature stimulus | GO:0009266 | 106 | 0.043 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 120 | 0.041 | |
| histone modification | GO:0016570 | 106 | 0.041 | |
| single organism catabolic process | GO:0044712 | 228 | 0.041 | |
| purine nucleoside metabolic process | GO:0042278 | 127 | 0.041 | |
| intracellular steroid hormone receptor signaling pathway | GO:0030518 | 12 | 0.040 | |
| posttranscriptional gene silencing | GO:0016441 | 46 | 0.039 | |
| nucleosome organization | GO:0034728 | 59 | 0.039 | |
| purine containing compound metabolic process | GO:0072521 | 155 | 0.039 | |
| nucleotide metabolic process | GO:0009117 | 161 | 0.039 | |
| regulation of transport | GO:0051049 | 181 | 0.037 | |
| regulation of cellular localization | GO:0060341 | 136 | 0.037 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 103 | 0.036 | |
| covalent chromatin modification | GO:0016569 | 106 | 0.036 | |
| regulation of transcription by chromatin organization | GO:0034401 | 3 | 0.036 | |
| nucleoside phosphate metabolic process | GO:0006753 | 162 | 0.035 | |
| response to heat | GO:0009408 | 63 | 0.035 | |
| negative regulation of signaling | GO:0023057 | 219 | 0.034 | |
| organonitrogen compound metabolic process | GO:1901564 | 318 | 0.033 | |
| nuclear division | GO:0000280 | 332 | 0.033 | |
| eye development | GO:0001654 | 323 | 0.033 | |
| regulation of cellular amine metabolic process | GO:0033238 | 3 | 0.032 | |
| response to organic substance | GO:0010033 | 284 | 0.032 | |
| positive regulation of phosphorus metabolic process | GO:0010562 | 139 | 0.032 | |
| endosomal transport | GO:0016197 | 44 | 0.032 | |
| purine ribonucleoside catabolic process | GO:0046130 | 112 | 0.032 | |
| regulation of hydrolase activity | GO:0051336 | 97 | 0.031 | |
| stem cell maintenance | GO:0019827 | 67 | 0.031 | |
| ribonucleotide catabolic process | GO:0009261 | 109 | 0.030 | |
| positive regulation of cellular biosynthetic process | GO:0031328 | 316 | 0.030 | |
| response to hexose | GO:0009746 | 3 | 0.029 | |
| dna conformation change | GO:0071103 | 105 | 0.029 | Human |
| negative regulation of cell cycle phase transition | GO:1901988 | 103 | 0.029 | |
| proteolysis | GO:0006508 | 192 | 0.028 | |
| detection of external stimulus | GO:0009581 | 66 | 0.028 | |
| negative regulation of cellular biosynthetic process | GO:0031327 | 277 | 0.028 | |
| cytoplasmic transport | GO:0016482 | 130 | 0.028 | |
| eye morphogenesis | GO:0048592 | 260 | 0.028 | |
| spermatid differentiation | GO:0048515 | 114 | 0.027 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 108 | 0.027 | |
| ribonucleotide metabolic process | GO:0009259 | 145 | 0.027 | |
| peptidyl lysine trimethylation | GO:0018023 | 6 | 0.027 | |
| mitotic sister chromatid segregation | GO:0000070 | 87 | 0.027 | |
| purine nucleotide metabolic process | GO:0006163 | 146 | 0.027 | |
| catabolic process | GO:0009056 | 409 | 0.026 | |
| mitotic spindle elongation | GO:0000022 | 81 | 0.026 | |
| histone h4 acetylation | GO:0043967 | 13 | 0.025 | |
| macromolecular complex assembly | GO:0065003 | 256 | 0.025 | |
| regulation of phosphate metabolic process | GO:0019220 | 210 | 0.025 | |
| positive regulation of histone h3 k9 methylation | GO:0051574 | 3 | 0.025 | |
| learning or memory | GO:0007611 | 141 | 0.024 | |
| body morphogenesis | GO:0010171 | 2 | 0.024 | |
| compound eye morphogenesis | GO:0001745 | 249 | 0.024 | |
| negative regulation of rna metabolic process | GO:0051253 | 251 | 0.023 | Human |
| regulation of phosphorus metabolic process | GO:0051174 | 210 | 0.023 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 108 | 0.023 | |
| purine ribonucleotide metabolic process | GO:0009150 | 145 | 0.023 | |
| positive regulation of intracellular signal transduction | GO:1902533 | 116 | 0.023 | |
| regulation of cellular component movement | GO:0051270 | 42 | 0.023 | |
| spermatogenesis | GO:0007283 | 200 | 0.023 | |
| establishment or maintenance of cell polarity | GO:0007163 | 167 | 0.023 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 119 | 0.023 | |
| lipid metabolic process | GO:0006629 | 121 | 0.022 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 39 | 0.022 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 119 | 0.022 | |
| cell death | GO:0008219 | 279 | 0.022 | Human |
| response to light stimulus | GO:0009416 | 124 | 0.022 | |
| forebrain development | GO:0030900 | 2 | 0.022 | |
| wing disc morphogenesis | GO:0007472 | 344 | 0.022 | |
| nucleoside metabolic process | GO:0009116 | 127 | 0.022 | |
| negative regulation of signal transduction by p53 class mediator | GO:1901797 | 1 | 0.022 | |
| single organism biosynthetic process | GO:0044711 | 206 | 0.022 | |
| organelle localization | GO:0051640 | 148 | 0.021 | |
| endocytosis | GO:0006897 | 310 | 0.021 | |
| meiotic cell cycle | GO:0051321 | 171 | 0.021 | |
| single organism behavior | GO:0044708 | 391 | 0.021 | |
| purine nucleotide catabolic process | GO:0006195 | 109 | 0.021 | |
| nucleobase containing compound catabolic process | GO:0034655 | 165 | 0.021 | |
| regulation of cellular component biogenesis | GO:0044087 | 201 | 0.021 | |
| response to oxygen containing compound | GO:1901700 | 200 | 0.021 | |
| chemical homeostasis | GO:0048878 | 92 | 0.020 | |
| photoreceptor cell development | GO:0042461 | 96 | 0.020 | |
| multi organism behavior | GO:0051705 | 175 | 0.020 | |
| cell cycle phase transition | GO:0044770 | 140 | 0.020 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 80 | 0.020 | |
| response to organic cyclic compound | GO:0014070 | 89 | 0.020 | |
| production of small rna involved in gene silencing by rna | GO:0070918 | 15 | 0.020 | |
| carbohydrate derivative catabolic process | GO:1901136 | 118 | 0.019 | |
| dna integrity checkpoint | GO:0031570 | 81 | 0.019 | |
| locomotory behavior | GO:0007626 | 176 | 0.019 | |
| negative regulation of cellular macromolecule biosynthetic process | GO:2000113 | 267 | 0.019 | |
| single organism intracellular transport | GO:1902582 | 207 | 0.019 | |
| negative regulation of organ growth | GO:0046621 | 15 | 0.018 | |
| compound eye photoreceptor development | GO:0042051 | 78 | 0.018 | |
| regulation of cell motility | GO:2000145 | 23 | 0.018 | |
| actin cytoskeleton organization | GO:0030036 | 206 | 0.018 | |
| regulation of catalytic activity | GO:0050790 | 185 | 0.018 | |
| nuclear pore organization | GO:0006999 | 1 | 0.018 | |
| regulation of gene silencing | GO:0060968 | 63 | 0.017 | |
| negative regulation of rna biosynthetic process | GO:1902679 | 240 | 0.017 | |
| programmed cell death | GO:0012501 | 257 | 0.017 | Human |
| rna export from nucleus | GO:0006405 | 12 | 0.017 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 119 | 0.017 | |
| neural precursor cell proliferation | GO:0061351 | 75 | 0.017 | |
| chromatin remodeling | GO:0006338 | 72 | 0.017 | |
| positive regulation of hydrolase activity | GO:0051345 | 78 | 0.017 | |
| organophosphate catabolic process | GO:0046434 | 112 | 0.016 | |
| response to dsrna | GO:0043331 | 15 | 0.016 | |
| regulation of multi organism process | GO:0043900 | 131 | 0.016 | |
| purine ribonucleotide catabolic process | GO:0009154 | 109 | 0.016 | |
| cell division | GO:0051301 | 248 | 0.016 | |
| apoptotic process | GO:0006915 | 159 | 0.016 | Human |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 119 | 0.016 | |
| male gamete generation | GO:0048232 | 201 | 0.016 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 77 | 0.016 | |
| regulation of catabolic process | GO:0009894 | 170 | 0.015 | |
| instar larval development | GO:0002168 | 55 | 0.015 | |
| signal transduction by phosphorylation | GO:0023014 | 107 | 0.015 | |
| regulation of ras protein signal transduction | GO:0046578 | 93 | 0.015 | |
| aromatic compound catabolic process | GO:0019439 | 166 | 0.015 | |
| neuron projection guidance | GO:0097485 | 241 | 0.014 | |
| spindle elongation | GO:0051231 | 83 | 0.014 | |
| axis specification | GO:0009798 | 167 | 0.014 | |
| regulation of g1 s transition of mitotic cell cycle | GO:2000045 | 23 | 0.014 | |
| positive regulation of signaling | GO:0023056 | 243 | 0.014 | |
| organic hydroxy compound metabolic process | GO:1901615 | 83 | 0.014 | |
| blastoderm segmentation | GO:0007350 | 159 | 0.014 | |
| g2 dna damage checkpoint | GO:0031572 | 69 | 0.014 | |
| positive regulation of molecular function | GO:0044093 | 136 | 0.014 | |
| regulation of protein localization | GO:0032880 | 76 | 0.014 | |
| regulation of small gtpase mediated signal transduction | GO:0051056 | 93 | 0.014 | |
| positive regulation of programmed cell death | GO:0043068 | 62 | 0.014 | Human |
| positive regulation of cellular protein metabolic process | GO:0032270 | 118 | 0.014 | |
| negative regulation of multicellular organismal process | GO:0051241 | 142 | 0.014 | |
| negative regulation of nitrogen compound metabolic process | GO:0051172 | 265 | 0.013 | Human |
| dna templated transcription elongation | GO:0006354 | 18 | 0.013 | |
| positive regulation of cell communication | GO:0010647 | 250 | 0.013 | |
| negative regulation of nucleic acid templated transcription | GO:1903507 | 240 | 0.013 | |
| olfactory learning | GO:0008355 | 56 | 0.013 | |
| organic substance catabolic process | GO:1901575 | 308 | 0.013 | |
| atp catabolic process | GO:0006200 | 38 | 0.013 | |
| negative regulation of imaginal disc growth | GO:0045571 | 8 | 0.013 | |
| positive regulation of response to stimulus | GO:0048584 | 323 | 0.013 | |
| ribonucleoside metabolic process | GO:0009119 | 127 | 0.013 | |
| chromatin assembly or disassembly | GO:0006333 | 52 | 0.013 | |
| negative regulation of nucleobase containing compound metabolic process | GO:0045934 | 261 | 0.013 | Human |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 38 | 0.013 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 55 | 0.013 | |
| cellular response to hexose stimulus | GO:0071331 | 1 | 0.013 | |
| regulation of lipid transport | GO:0032368 | 3 | 0.012 | |
| lipid localization | GO:0010876 | 54 | 0.012 | |
| nuclear body organization | GO:0030575 | 6 | 0.012 | |
| phagocytosis | GO:0006909 | 215 | 0.012 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 24 | 0.012 | |
| regulation of organelle organization | GO:0033043 | 196 | 0.012 | |
| regulation of cell junction assembly | GO:1901888 | 2 | 0.012 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 165 | 0.012 | |
| mitotic dna damage checkpoint | GO:0044773 | 74 | 0.012 | |
| phosphorylation | GO:0016310 | 294 | 0.012 | |
| interspecies interaction between organisms | GO:0044419 | 16 | 0.012 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 117 | 0.012 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 38 | 0.012 | |
| positive regulation of heterochromatin assembly | GO:0031453 | 5 | 0.012 | |
| oocyte axis specification | GO:0007309 | 108 | 0.012 | |
| death | GO:0016265 | 284 | 0.012 | Human |
| rna splicing via transesterification reactions with bulged adenosine as nucleophile | GO:0000377 | 73 | 0.012 | Human |
| alternative mrna splicing via spliceosome | GO:0000380 | 60 | 0.011 | |
| regulation of mrna metabolic process | GO:1903311 | 72 | 0.011 | Human |
| positive regulation of catabolic process | GO:0009896 | 105 | 0.011 | |
| positive regulation of cell proliferation | GO:0008284 | 47 | 0.011 | |
| cellular macromolecular complex assembly | GO:0034622 | 153 | 0.011 | |
| regulation of cellular protein metabolic process | GO:0032268 | 243 | 0.011 | |
| positive regulation of protein metabolic process | GO:0051247 | 128 | 0.011 | |
| cellular response to organic substance | GO:0071310 | 132 | 0.011 | |
| regulation of molecular function | GO:0065009 | 217 | 0.011 | |
| positive regulation of stem cell differentiation | GO:2000738 | 3 | 0.011 | |
| secretion | GO:0046903 | 109 | 0.011 | |
| sister chromatid segregation | GO:0000819 | 92 | 0.010 | |
| glycosyl compound metabolic process | GO:1901657 | 127 | 0.010 | |
| cellular response to nitrogen compound | GO:1901699 | 51 | 0.010 | |
| regulation of embryonic development | GO:0045995 | 68 | 0.010 | |
| stem cell division | GO:0017145 | 69 | 0.010 | |
| histone h3 k4 methylation | GO:0051568 | 16 | 0.010 | |
| negative regulation of cell cycle | GO:0045786 | 116 | 0.010 | |
